Regulatory Updates
Sep 24, 2026•1 min read
FDA Approves GLOPERBA Oral Colchicine Solution (NDA 210942)
Scilex Pharmaceuticals' GLOPERBA, an oral colchicine solution (0.6 mg/5 mL), received FDA approval under NDA 210942, with supplemental updates in 2021 and 2024.
Regulatory Updates
Aug 30, 2026•1 min read
FDA Approves ANDA 084279 for Probenecid and Colchicine Oral Tablet
The FDA has approved ANDA 084279 for a prescription oral tablet combining 500 mg probenecid and 0.5 mg colchicine, marketed by Actavis Pharma.